Literature DB >> 20217072

SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.

Neelam Dhiman1, Iana H Haralambieva, Richard B Kennedy, Robert A Vierkant, Megan M O'Byrne, Inna G Ovsyannikova, Robert M Jacobson, Gregory A Poland.   

Abstract

An effective immune response to vaccination is, in part, a complex interaction of alleles of multiple genes regulating cytokine networks. We conducted a genotyping study of Th1/Th2/inflammatory cytokines/cytokine receptors in healthy children (n = 738, 11-19 years) to determine associations between individual single-nucleotide polymorphisms (SNPs)/haplotypes and immune outcomes after two doses of rubella vaccine. SNPs (n = 501) were selected using the ldSelect-approach and genotyped using Illumina GoldenGate and TaqMan assays. Rubella-IgG levels were measured by immunoassay and secreted cytokines by ELISA. Linear regression and post hoc haplotype analyses were used to determine associations between single SNPs/haplotypes and immune outcomes. Increased carriage of minor alleles for the promoter SNPs (rs2844482 and rs2857708) of the TNFA gene were associated with dose-related increases in rubella antibodies. IL-6 secretion was co-directionally associated (p < or = 0.01) with five intronic SNPs in the TNFRSF1B gene in an allele dose-related manner, while five promoter/intronic SNPs in the IL12B gene were associated with variations in IL-6 secretion. TNFA haplotype AAACGGGGC (t-statistic = 3.32) and IL12B promoter haplotype TAG (t-statistic = 2.66) were associated with higher levels of (p < or = 0.01) rubella-IgG and IL-6 secretion, respectively. We identified individual SNPs/haplotypes in TNFA/TNFRSF1B and IL12B genes that appear to modulate immunity to rubella vaccination. Identification of such "genetic fingerprints" may predict the outcome of vaccine response and inform new vaccine strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20217072      PMCID: PMC2863092          DOI: 10.1007/s00251-010-0423-6

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  64 in total

1.  Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands.

Authors:  S Y Chu; R H Bernier; J A Stewart; K L Herrmann; J R Greenspan; A K Henderson; A P Liang
Journal:  JAMA       Date:  1988-06-03       Impact factor: 56.272

2.  Production of interferon by human peripheral lymphocytes stimulated with rubella virus.

Authors:  T Nakayama; T Urano; M Osano; M Nakagawa; N Maehara; K Sasaki; S Makino
Journal:  Kitasato Arch Exp Med       Date:  1988-12

3.  Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Authors:  G J Kurtzman; B J Cohen; A M Field; R Oseas; R M Blaese; N S Young
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

4.  2',5'-Oligoadenylate synthetase and interferon in peripheral blood after rubella, measles, or mumps live virus vaccine.

Authors:  J G Tilles; F Balkwill; J Davilla
Journal:  Proc Soc Exp Biol Med       Date:  1987-10

5.  Persistence of rubella antibodies 15 years after subcutaneous administration of Wistar 27/3 strain live attenuated rubella virus vaccine.

Authors:  I B Hillary; A H Griffith
Journal:  Vaccine       Date:  1984-12       Impact factor: 3.641

6.  Interleukin-4-mediated downregulation of cytotoxic T lymphocyte activity is associated with reduced proliferation of antigen-specific CD8+ T cells.

Authors:  Michael S Rolph; Ian A Ramshaw
Journal:  Microbes Infect       Date:  2003-09       Impact factor: 2.700

7.  Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age.

Authors:  R Singh; T J John; T Cherian; P Raghupathy
Journal:  Indian J Med Res       Date:  1994-10       Impact factor: 2.375

8.  Interferon-induced 2-5A synthetase activity in human peripheral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines.

Authors:  L J Penn; B R Williams
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

9.  Replication of rubella virus in human mononuclear blood cells.

Authors:  J T van der Logt; A M van Loon; J van der Veen
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

10.  Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination.

Authors:  Alexander L Pukhalsky; Galina V Shmarina; Maria S Bliacher; Irina M Fedorova; Anna P Toptygina; Julia J Fisenko; Vladimir A Alioshkin
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711

View more
  30 in total

1.  The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Robert A Vierkant; Megan M O'Byrne; Robert M Jacobson; Gregory A Poland
Journal:  Hum Hered       Date:  2011-11-11       Impact factor: 0.444

2.  The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Hum Genet       Date:  2011-03-19       Impact factor: 4.132

Review 3.  Vaccinomics: current findings, challenges and novel approaches for vaccine development.

Authors:  Inna G Ovsyannikova; Gregory A Poland
Journal:  AAPS J       Date:  2011-06-14       Impact factor: 4.009

Review 4.  Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Robert M Jacobson
Journal:  OMICS       Date:  2011-07-06

5.  Common SNPs/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African Americans.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Neelam Dhiman; Richard B Kennedy; Megan O'Byrne; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2011-08-01       Impact factor: 5.226

6.  Discrimination of single-point mutations in unamplified genomic DNA via Cas9 immobilized on a graphene field-effect transistor.

Authors:  Sarah Balderston; Jeffrey J Taulbee; Elizabeth Celaya; Kandace Fung; Amanda Jiao; Kasey Smith; Reza Hajian; Giedrius Gasiunas; Simonas Kutanovas; Daehwan Kim; Jonathan Parkinson; Kenneth Dickerson; Juan-José Ripoll; Regis Peytavi; Hsiang-Wei Lu; Francie Barron; Brett R Goldsmith; Philip G Collins; Irina M Conboy; Virginijus Siksnys; Kiana Aran
Journal:  Nat Biomed Eng       Date:  2021-04-05       Impact factor: 25.671

7.  Vaccines, reverse vaccinology, and bacterial pathogenesis.

Authors:  Isabel Delany; Rino Rappuoli; Kate L Seib
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

8.  Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Megan M O'Byrne; Robert M Jacobson; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-20       Impact factor: 3.641

9.  Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Nathaniel D Lambert; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2014-05-09       Impact factor: 2.846

10.  Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Nathaniel D Lambert; V Shane Pankratz; Gregory A Poland
Journal:  Hum Genet       Date:  2014-08-07       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.